Granules India Block Deal: Promoter Sells ₹1,509 Cr Stake, Global Giants Step In

Institutional block window counters witnessed major trading action on Friday as Granules India Limited recorded a massive secondary market block transaction totaling ₹1,509 crore on the National Stock Exchange of India. Company promoter Krishna Prasad divested 1.72 crore equity shares (17.2 million shares), accounting for approximately 6.9 percent of the paid-up equity base of the Hyderabad-headquartered pharmaceutical major. Executed at a negotiated floor benchmark of ₹872.50 per share, the transaction saw instant absorption by a consortium of global sovereign and asset management giants alongside top-tier domestic institutional funds.

Smallcap World Fund, BNP Paribas, and Goldman Sachs Scoop Up Shares

The substantial promoter equity sale on the exchange was swiftly matched by bids from leading institutional asset managers, all executed at the uniform settlement price of ₹872.50 per equity share:

• Smallcap World Fund: Picked up the largest institutional slice by buying 34.74 lakh equity shares, equivalent to a 1.4 percent equity stake, for a total consideration of ₹303 crore.

• BNP Paribas: Secured 13.2 lakh equity shares, capturing a 0.53 percent holding in the pharma manufacturer, for an outlay of ₹115 crore.

• Goldman Sachs: Acquired 11.73 lakh equity shares, establishing a 0.47 percent equity position, valued at ₹102 crore.

• Kotak Mahindra Life Insurance: Absorbed 11.54 lakh equity shares, securing a 0.47 percent equity stake, for an investment of ₹101 crore.

Pharma Stock Hits New 52-Week High Despite Large Promoter Offload

Despite the massive volume of secondary shares entering open circulation, Granules India shares showed strong buying absorption throughout the trading session. The counter concluded Friday's trading at ₹909.65, booking a solid gain of ₹8.15 or 0.90 percent over its prior close of ₹901.50. During intra-day price action, the stock touched a fresh 52-week peak of ₹914.55 against a daily session trough of ₹880.75, comfortably outperforming its session Volume-Weighted Average Price (VWAP) of ₹897.03.

Valuation Overview: Market Capitalization Surpasses ₹22,500 Crore

Following the transaction, Granules India’s aggregate market capitalization stood at ₹22,540.85 crore, with its free-float market capitalization pegged at ₹13,163.97 crore. A key component of the benchmark BSE 500 index within the active pharmaceutical ingredients and formulations space, the stock holds a nominal equity face value of ₹1 per share. Having rebounded sharply from its 52-week bottom of ₹511.00 recorded earlier in the year, the pharmaceutical counter continues to demonstrate persistent institutional accumulation and steady momentum heading into upcoming trading cycles.